Navigation Links
Kentucky's PSE Blocking Technology Leading To Progress In Battle Against Meth
Date:10/31/2012

LUTHERVILLE, Md., Oct. 31, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today released the latest results achieved by the real-time, stop-sale system in Kentucky.  Data aggregated through the National Precursor Log Exchange (NPLEx) for the first three quarters of 2012 shows electronic technology in the Bluegrass State blocked the sale of more than 24,000 boxes of medicines containing pseudoephedrine (PSE) preventing more than 62,000 grams from potentially being diverted by meth criminals.

"While the Commonwealth of Kentucky continues to wage a long battle against methamphetamine cooks and dealers, retailers around the state are seeing results using real-time, stop-sale technology that blocks unlawful attempted purchases of products containing pseudoephedrine," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "With thousands of blocks each month, Kentucky law enforcement officials can access valuable criminal data in real time. Officers can receive alerts when a suspect has exceeded his pseudoephedrine purchasing limits or when a pharmacy makes an abnormal number of sales in a given time period. By targeting criminals, NPLEx ensures that responsible Kentuckians will continue to have access to the cold and medicines of their choice."

About NADDI

The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion.  NADDI also sponsors and conducts specialized educational seminars and conferences.


'/>"/>
SOURCE National Association of Drug Diversion Investigators
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Parker Signs Licensing Agreement with Vanderbilt for Exoskeleton Technology and Targets Commercial Launch in 2014
2. West Health Institute licenses Kinect-based physical therapy technology to Reflexion Health; West Health Investment Fund makes $4.25 million investment
3. Goodwin Biotechnology is a Three-Category Winner in the 2012 CMO Leadership Awards
4. Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare
5. Medical Virtual Reality Technology Nominated Twice in the 2012 Accenture Innovation Awards
6. DICOM Grid Collaborates with Mayo Clinic on Mobile Image Viewing Technology
7. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
8. Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance
9. Assisted Reproduction: New Technology Identifies Previously Unknown Predictors of Embryo Viability
10. Caliber IDs VivaScope technology found to be 100% sensitive for basal cell carcinoma diagnosis
11. Pomona Valley Hospital is First in the Region to Use Innovative Technology for Neonates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery Institute ... pageant as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic surgeon, ... , Dr. Olson says the decision to support the pageant in an official ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Today, ... optimize the ingestion of their medication by matching users with high quality water pipes ... compare pieces with no commitment. , Inhale was founded by two brothers, Nick and ...
(Date:6/23/2016)... ... June 23, 2016 , ... An article published June 8 ... between head and neck cancer in individuals with unhealthy oral hygiene habits. The article ... on whether they had gum disease, brushed their teeth on a daily basis, wore ...
Breaking Medicine News(10 mins):